Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecularly-Guided Phase II Umbrella Trial for Children, Adolescents, and Young Adults Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma

NCT05839379 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT05839379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05839379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecularly-Guided Phase II Umbrella Trial for Children, Adolescents, and Young Adults Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma
Lead sponsor
Nationwide Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 2, 2024
Completion date
August 28, 2034
Enrollment
350 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, diffuse intrinsic pontine glioma, diffuse midline glioma, h3 k27m-mutant, glioblastoma, glioblastoma multiforme, high grade glioma, metastatic brain tumor, who grade iii glioma, who grade iv glioma